BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Biodefense
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20200308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20201101T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20210314T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20211107T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20220313T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20221106T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210707
DTEND;VALUE=DATE:20210710
DTSTAMP:20210226T214129Z
CREATED:20210226T214129Z
LAST-MODIFIED:20210226T214129Z
UID:48691-1625616000-1625875199@globalbiodefense.com
SUMMARY:New Approaches and Concepts in Microbiology
DESCRIPTION:The New Approaches and Concepts in Microbiology will take place 7-9 July 2021 in a virtual format. \nThe event will cover a broad range of topics in microbiology\, including antibiotic-related research\, bacterial communities and microbiome\, cell biology\, regulation & signalling\, pathogenesis and evolution. Emphasis will be placed on novel approaches and technologies (from systems-based to single-cell) that drive each field or have the potential to revolutionise future research in microbiology. \nThis must-attend event for scientists working with bacteria and new technologies. The focus remains on the interface of new technologies and new biology in bacteria\, but the thematic areas change and speaker line-ups do not overlap between consecutive symposia. \nThis symposium aims at bridging the gap between traditional microbiology and novel technologies\, by exposing microbiologists to new ways of addressing their hypotheses. At the same time\, it provides a platform for systems or technology experts to get a better understanding of the important questions in the field. \nHighlighted sessions and focus areas include:\nBacterial systems biology\nCell biology and protein machineries\nRegulation\, signalling and transcriptional networks\nPathogenesis and infection\nAntibiotic action-resistance-persistance\nMicrobial communities / microbiotas / symbiosis\nEvolution and ecology \nPlease visit EMBO | EMBL’s New Approaches and Concepts in Microbiology page for more information.
URL:https://globalbiodefense.com/event/new-approaches-and-concepts-in-microbiology/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210608
DTEND;VALUE=DATE:20210610
DTSTAMP:20210124T013522Z
CREATED:20210124T013522Z
LAST-MODIFIED:20210124T013522Z
UID:48301-1623110400-1623283199@globalbiodefense.com
SUMMARY:Pivotal Interfaces of Environmental Health and Infectious Disease Research to Inform Responses to Outbreaks
DESCRIPTION:This workshop will explore how environmental health tools\, technologies\, and methodologies can be leveraged to inform real-time public health decision making about infectious disease outbreaks\, epidemics\, and pandemics. The workshop may feature several case studies of infectious disease outbreaks for which spread and exposure is mediated\, in part\, by environmental pollution and conditions. \nAn ad hoc planning committee of the National Academies of Sciences\, Engineering\, and Medicine will organize and convene a workshop to explore how environmental health tools\, technologies\, and methodologies can be leveraged to inform real-time public health decision making about infectious disease outbreaks\, epidemics\, and pandemics. The workshop may feature several case studies of infectious disease outbreaks for which spread and exposure is mediated\, in part\, by environmental pollution and conditions\, through the following questions: \n1) How can advances in environmental exposure assessment be applied to identify\, predict\, or monitor critical pathways by which humans are exposed to infectious agents? \n2)  How can recent advances in climate and environmental health modeling techniques be applied to better understand the biology of pathogens\, vectors\, and hosts; predict transmission dynamics; and provide early warning of emerging infectious diseases? \n3) How can environmental pollutants exposure models and data integration approaches be leveraged to predict population vulnerability/risk to infection? \n4) How sensitive is the initial emergence of infectious disease outbreaks to variations in environmental conditions? \nThe presentations and discussions at the workshop will be documented in a workshop proceedings\, written by a designated rapporteur in accordance with institutional guidelines.
URL:https://globalbiodefense.com/event/pivotal-interfaces-of-environmental-health-and-infectious-disease-research-to-inform-responses-to-outbreaks/
CATEGORIES:Conference,Webinar-Webcast,Workshop
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20210527T153000
DTEND;TZID=Europe/London:20210527T163000
DTSTAMP:20210518T201503Z
CREATED:20210518T201503Z
LAST-MODIFIED:20210518T201503Z
UID:49248-1622129400-1622133000@globalbiodefense.com
SUMMARY:Maximum Containment Labs Around the World
DESCRIPTION:Join Dr. Filippa Lentzos and Dr. Gregory D. Koblentz for a briefing on 27 May 2021 on a new resource on global BSL4 labs and biorisk management policies. \nThis public webinar\, held on the side lines of the seventy-fourth World Health Assembly meeting\, will launch globalbiolabs.org\, an interactive web-based map of global Biosafety Level-4 facilities and biorisk management policies. An accompanying policy brief\, entitled ‘Mapping Maximum Biological Containment Labs Globally’\, will also be released. \n 
URL:https://globalbiodefense.com/event/maximum-containment-labs-around-the-world/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://us02web.zoom.us/webinar/register/WN_HuZbZ7SbS8OvljyRYr9-nA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20210527T133000
DTEND;TZID=Europe/Paris:20210527T144500
DTSTAMP:20210518T223618Z
CREATED:20210501T222833Z
LAST-MODIFIED:20210518T223618Z
UID:49253-1622122200-1622126700@globalbiodefense.com
SUMMARY:Advancing Gender Perspectives in the Biological Weapons Convention
DESCRIPTION:The International Gender Champions Disarmament Impact Group and the BWC Implementation Support Unit welcome you to an interactive discussion on 27 May on the relevance of gender perspectives to the implementation of the Biological Weapons Convention. \nThe discussion will address recent initiatives to improve women’s meaningful participation in the BWC\, as well as research on sex-specific and gendered impacts of biological weapons. \nPanelists will take stock of how gender perspectives are already being incorporated into BWC discussions and\, in view of the forthcoming Ninth BWC Review Conference\, how they can be further promoted and strengthened in future BWC work programmes. \nThe event will also mark the launch of a new factsheet by the Disarmament Impact Group on “Gender and Biological Weapons”. \n 
URL:https://globalbiodefense.com/event/advancing-gender-perspectives-in-the-biological-weapons-convention/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://rtce-unog.webex.com/mw3300/mywebex/default.do?nomenu=true&siteurl=rtce-unog&service=6&rnd=0.4655756273962446&main_url=https%3A%2F%2Frtce-unog.webex.com%2Fec3300%2Feventcenter%2Fevent%2FeventAction.do%3FtheAction%3Ddetail%26%26%26EMK%3D4832534b00000004346873833f32d707b10d18ee70fc3d5c8c3d215ec63e9ede0c9f7e79edd173a2%26siteurl%3Drtce-unog%26confViewID%3D194014003524017497%26encryptTicket%3DSDJTSwAAAAQm5DyOP2TNxCQgIiR4ZmkiGlbFK2NrgnXV1zaYNmQKdw2%26
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210526T110000
DTEND;TZID=America/New_York:20210526T120000
DTSTAMP:20210525T214033Z
CREATED:20210516T211111Z
LAST-MODIFIED:20210525T214033Z
UID:49261-1622026800-1622030400@globalbiodefense.com
SUMMARY:U.S. Leadership for a Pandemic-Free Future: Technologies to End Biological Threats
DESCRIPTION:The Capitol Hill Steering Committee on Pandemic Preparedness and Health Security will convene for a webcast event on “U.S. Leadership for a Pandemic-Free Future: Technologies to End Biological Threats” on Wednesday\, May 26\, 2021. \nThis webinar will explore how the federal government can prioritize investments in available and future technologies to ensure nothing like the Covid-19 pandemic\, or worse\, could ever happen again. \nThe Steering Committee hosts monthly events focused on lessons learned from responses to natural\, man-made\, and other complex health emergencies\, such as the COVID-19 pandemic\, and how to better mitigate and respond to future health crises. \nThe Steering Committee is sponsored and managed by Johns Hopkins Center for Health Security. Six United States Senators serve as Honorary Senate Co-Chairs\, Four United States House of Representatives serve as Honorary House Co-Chairs and 4 former federal government public health leaders serve as Honorary Founding Members. \nHonorary Senate Co-Chairs \n\nSenator Tammy Baldwin (D-WI)\nSenator Richard Burr (R-NC)\nSenator Ben Cardin (D-MD)\nSenator Bob Casey (D-PA)\nSenator Cindy Hyde-Smith (R-MS)\n\nSenator Chris Van Hollen (D-MD)\n\n\nHonorary House of Representatives Co-Chairs \n\nRepresentative Rosa DeLauro (D-CT)\nRepresentative Anna Eshoo (D-CA)\nRepresentative Andy Harris (R-MD)\nRepresentative Richard Hudson (R-NC)\n\nHonorary Founding Members \n\nSusan Brooks\, JD\, Former U.S. House of Representative (R-IN)\nStephen Redd\, MD\, Former Deputy Director for Public Health Service and Implementation Science\, US Centers for Disease Control and Prevention; Rear Admiral Retired\, US Public Health Service\nKathleen Sebelius\, MPA\, Former Secretary\, US Department of Health and Human Services\, former Governor of Kansas\nW. Craig Vanderwagen\, MD\, Former Assistant Secretary for Preparedness and Response\, US Department of Health and Human Services\, Rear Admiral Retired\, US Public Health Service
URL:https://globalbiodefense.com/event/u-s-leadership-for-a-pandemic-free-future-technologies-to-end-biological-threats/
LOCATION:https://jh.zoom.us/webinar/register/WN_bE6b6oFDSyS3C2a3WWEleA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210520T090000
DTEND;TZID=America/New_York:20210520T110000
DTSTAMP:20210520T140902Z
CREATED:20210501T140556Z
LAST-MODIFIED:20210520T140902Z
UID:49256-1621501200-1621508400@globalbiodefense.com
SUMMARY:The Future of Global Health Security
DESCRIPTION:Join Dr. Tom Frieden and the Prevent Epidemics team of Resolve to Save Lives\, an initiative of Vital Strategies\, to discuss lessons from past outbreaks\, preparedness successes\, and the need to invest and prioritize funding to fight the next pandemic. The event will call on political and public health leaders to increase global collaboration and work together at the global\, regional\, country\, and local levels to build a more resilient response to future health emergencies. For more information pandemic preparedness\, read our recent report Epidemics that Didn’t Happen.
URL:https://globalbiodefense.com/event/the-future-of-global-health-security/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://preventepidemics.org/globalhealthsecurityevent/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210518
DTEND;VALUE=DATE:20210519
DTSTAMP:20210518T222659Z
CREATED:20210318T222200Z
LAST-MODIFIED:20210518T222659Z
UID:49251-1621296000-1621382399@globalbiodefense.com
SUMMARY:CBRNE Research and Innovation 2021
DESCRIPTION:The International e-Conference on CBRNE Research & Innovation will take place May 18\, 2021. \nHighlighted topics include: \n\nRecycling protective garments processes and techniques used for decontaminating and removing unwanted organic substances\nOnline tools for assessment of factors associated with SARS-CoV-2 infection\, and evaluation of new prophylactic and therapeutic drug regimens against COVID-19\nDiscovery tools in preparedness and response to NRBC threats\nPReparedness against CBRNE threats through cOmmon Approaches between security praCTItioners and the VulnerablE civil society (PROACTIVE)\nEuropean Network of CBRN Training Centers: just-in-time training and evolving training methodologies for first responders\n\nThe virtual format event builds on the success of the first 3 international conferences which tool place in Antibes (2015)\, Lyon (2017) and Nantes (2019) and will serve as a professional bridge until the next in-person conference at Lille in May 2022. \nhttps://cbrneconference.fr/ \n  \n 
URL:https://globalbiodefense.com/event/cbrne-research-and-innovation-2021/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://cbrneconference.fr/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210511T110000
DTEND;TZID=America/New_York:20210511T150000
DTSTAMP:20201127T193923Z
CREATED:20201127T193923Z
LAST-MODIFIED:20201127T193923Z
UID:48065-1620730800-1620745200@globalbiodefense.com
SUMMARY:Envisioning a Transformed Clinical Trials Enterprise for 2030 - Session 4
DESCRIPTION:The National Academies’ Forum on Drug Discovery\, Development\, and Translation will host a virtual public workshop on May 11\, 2021 as part of a web series forum of events to discuss critical policy for advancement of biopharmaceutical innovation nationally and globally. \nThis virtual public workshop will provide a venue for stakeholders to consider a transformed clinical trial enterprise for 2030. Workshop participants will consider lessons learned from progress and setbacks over the past 10 years\, since the previous workshop\, Envisioning a Transformed Clinical Trials Enterprise in the United States\, and\, looking forward\, discuss goals and key priorities for advancing a clinical trials enterprise that is more efficient\, effective\, person-centered\, inclusive\, and integrated into the health delivery system of 2030. \nThe event will consider ways the thoughtful and deliberate use of new technologies could improve the clinical trials enterprise and support goals outline in prior webinar sessions. \nBackground\nClinical trials research has changed dramatically over the last decade. The biological\, physical\, and digital spheres are merging; clinical research and health care are at a critical juncture; new approaches enable the collection of data in real-world settings; and new modalities\, such as digital health technologies and artificial intelligence applications\, are changing possibilities for the conduct of clinical research. \nA planning committee of the National Academies of Sciences\, Engineering\, and Medicine will plan and conduct a virtual public workshop designed to consider a transformed clinical trial enterprise for 2030. Key priority challenges and opportunities framing the 2030 agenda are: \n\nDiversity and inclusion of clinical trial participants\nConvergence of clinical research and clinical practice\nClinical trial data sharing\nIncorporation of new technologies into drug research and development\nWorkforce and career development\nPublic engagement and partnership\nRegulatory Environment\nCultural and Financial Incentives\nPractical short- and long-term goals for improving the efficiency\, effectiveness\, person-centeredness\, inclusivity\, and integration with healthcare of the clinical trials enterprise.\n\nPlanning Committee\n\nSteven Galson (Co-Chair)\, Amgen\nEster Krofah (Co-Chair)\, FasterCures\, Milken Institute\nAmy Abernethy\, Office of the Comissioner\, FDA\nAnita LaFrance Allen\, University of Pennsylvania\nChristopher P. Austin\, National Center for Advancing Translational Sciences\, NIH\nHoward A. Burris\, Sarah Cannon\nLuther T. Clark\, Merck & Co.\, Inc.\nGiselle Corbie-Smith\, The University of North Carolina at Chapel Hill\nM. Khair ElZarrad\, Center for Drug Evaluation and Research\, FDA\nJennifer Goldsack\, Digital Medicine Society\nRichard A. Moscicki\, PhRMA\nAmy Patterson\, National Heart\, Lung\, and Blood Institute\, NIH\nJoseph Scheeren\, Critical Path Institute\nAnantha Shekhar\, University of Pittsburgh\nPamela Tenaerts\, Clinical Trials Transformation Initiative\nChristopher Yoo\, Systems Oncology\n\nFor additional information on the workshop series\, please visit the project page.
URL:https://globalbiodefense.com/event/envisioning-a-transformed-clinical-trials-enterprise-for-2030-session-4/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:https://bit.ly/nasem-clinicaltrialenterprise
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210504T160000
DTEND;TZID=America/Los_Angeles:20210504T180000
DTSTAMP:20240623T231246Z
CREATED:20210225T161815Z
LAST-MODIFIED:20240623T231246Z
UID:48633-1620144000-1620151200@globalbiodefense.com
SUMMARY:Reporting Science to Public & How 'Science' Adapts to the Pandemic
DESCRIPTION:A virtual presentation on “Reporting Science to Public & How ‘Science’ Adapts to the Pandemic” will be held on May 4\, 2021 as part of the 2021 Demystifying Medicine Series. \nThe 2021 Demystifying Medicine Series\, which is jointly sponsored by FAES and NIH\, will begin January 12 and includes the presentation of patients\, pathology\, diagnosis and therapy in the context of major disease problems and current research. Primarily directed toward Ph.D. students\, clinicians and program managers\, the course is designed to help bridge the gap between advances in biology and their application to major human diseases. Each session includes clinical and basic science components presented by NIH staff and invitees. All students\, fellows and staff are welcome\, as well. \nAbout the Speakers \n~ Stephen Smith (Washington Post Health and Science Editor) \n~ Valda Vinson\, PhD (Science Editor) – Valda Vinson is Editor (Research) at Science. She came to the United States as a Fulbright scholar and after completing a Ph.D and post-doctoral studies\, spent 2 years as a Senior Lecturer at the University of the Western Cape. She started her career in publishing when she joined the Science staff in 1999. Since then\, she has handled research papers in the areas of structural biology\, biochemistry\, and biophysics as an Associate and Senior Editor. In 2013 Dr. Vinson became Deputy Editor\, overseeing research content in the areas of cellular and molecular biology and biomedicine\, and in 2018 was named Editor\, Research. As Editor she works with Life Science editors to attract and select exciting research papers and reviews\, while following standards that support transparency and reproducibility. She also works with others on the editorial management team on editorial policies at Science and is involved in initiatives that bring together stake-holders within the publishing industry to discuss policies. \nPlease visit the NIH Demystifying Medicine website for more information.
URL:https://globalbiodefense.com/event/reporting-science-to-public-how-science-adapts-to-the-pandemic/
CATEGORIES:Government Hosted,Webinar-Webcast,Workshop
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210420
DTEND;VALUE=DATE:20210424
DTSTAMP:20200323T175402Z
CREATED:20200228T040200Z
LAST-MODIFIED:20200323T175402Z
UID:40443-1618876800-1619222399@globalbiodefense.com
SUMMARY:ABSA's 1st Biosecurity Symposium
DESCRIPTION:Due to the COVID-19 pandemic\, ABSA’s 1st Biosecurity Symposium has been rescheduled and will now take place 20-23 April 2020 in Minneapolis\, MN. \nABSA International’s 1st Biosecurity Symposium will galvanize and bring together biosecurity professionals from a wide range of disciplines with varying expertise to share their experiences and knowledge\, and to learn from each other. \nThe agenda includes themes on biosecurity governance\, implementation\, personnel reliability\, bioeconomy\, biosecurity in DIYbio communities\, biosecurity training\, cyberbiosecurity\, and interactive discussions on lessons learned and public engagement for the future. The symposium will showcase thought-provoking leaders and pioneering researchers from various traditional and non-traditional fields that intersect with biosecurity. A segment on new and emerging topics in biosecurity will also be featured. \nPlease visit ABSA’s 1st Biosecurity Symposium website for more information. \n 
URL:https://globalbiodefense.com/event/absas-1st-biosecurity-symposium/
LOCATION:Renaissance Depot Hotel\, 225 3rd Ave S\, Minneapolis\, MN\, 55401\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210420
DTEND;VALUE=DATE:20210422
DTSTAMP:20210227T184218Z
CREATED:20210227T184218Z
LAST-MODIFIED:20210227T184218Z
UID:48698-1618876800-1619049599@globalbiodefense.com
SUMMARY:APBI 2021 - APG Advanced Planning Briefing to Industry
DESCRIPTION:Team Aberdeen Proving Ground (APG) is hosting the APG Advanced Planning Briefing to Industry (APBI) on April 20-21\, 2021 via virtual format. \nThe goal of the APG APBI is to describe for industry potential future contracting opportunities for mission areas that focus on: \n\nChemical and Biological Defense\nCommand\, Control\, Communications\, Computers\, Cyber\, Intelligence\, Surveillance\, and Reconnaissance\nResearch and Development\nTest and Evaluation\nAPG Garrison\n\nThe APG APBI will be unclassified and open to all interested contractors\, large and small businesses\, and academia\, as well as other Government stakeholders. \nAdditional details will be posted at beta.SAM.gov as updates become available.
URL:https://globalbiodefense.com/event/apbi-2021-apg-advanced-planning-briefing-to-industry/
CATEGORIES:Government Hosted,Industry Day,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210407T183000
DTEND;TZID=America/New_York:20210407T200000
DTSTAMP:20240118T180225Z
CREATED:20210308T082324Z
LAST-MODIFIED:20240118T180225Z
UID:48783-1617820200-1617825600@globalbiodefense.com
SUMMARY:Schar School of Policy and Government: Master’s and Certificate Virtual Open House
DESCRIPTION:Master’s and Certificate Virtual Open House\nApril 7\, 2021 6:30 p.m. – 8:00 p.m. ET \nLearn more about the Schar School of Policy and Government and our academic programs at a virtual open house. The online session will provide an overview of our master’s degree and graduate certificate programs\, student services\, and admissions requirements. \nLearn more: http://bit.ly/scharopenhouse2021
URL:https://globalbiodefense.com/event/schar-school-of-policy-and-government-masters-and-certificate-virtual-open-house/
CATEGORIES:Webinar-Webcast
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2021/03/gmu-schar-school-open-house-large-1200.png
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210330T170000
DTEND;TZID=America/Los_Angeles:20210330T180000
DTSTAMP:20210223T212911Z
CREATED:20210223T212911Z
LAST-MODIFIED:20210223T212911Z
UID:48590-1617123600-1617127200@globalbiodefense.com
SUMMARY:Model Me This: COVID-19 Scientific Predictions and Where We Go From Here
DESCRIPTION:The Pacific Northwest National Laboratory will host a virtual Demystifying COVID Seminar Series event entitled\, “COVID-19 Scientific Predictions and Where We Go From Here” on March 30\, 2021. \nThe Pacific Northwest National Laboratory’s Community Science and Technology Seminar Series was launched to help the general public better understand and explore how science transforms our world. \nABOUT THE SPEAKER \nDr. Tim Scheibe is the lead scientist for PNNL’s River Corridor Scientific Focus Area project. He develops the scientific vision for multiscale and computational science within the Environmental Molecular Sciences Division and frequently offers a national perspective on future scientific and technological needs. He specializes in multiscale modeling\, including parameter estimation and mitigating uncertainty. \nRegister for the event here.
URL:https://globalbiodefense.com/event/model-me-this-covid-19-scientific-predictions-and-where-we-go-from-here/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://pnnl.zoomgov.com/webinar/register/WN_KH262WbnSJqKRCe_u1bCJQ
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210330T160000
DTEND;TZID=America/New_York:20210330T180000
DTSTAMP:20210225T161411Z
CREATED:20210225T161411Z
LAST-MODIFIED:20210225T161411Z
UID:48631-1617120000-1617127200@globalbiodefense.com
SUMMARY:How COVID-19 Pandemic Changes Medical Research\, Teaching and Patient Care
DESCRIPTION:A virtual presentation on “How COVID-19 Pandemic Changes Medical Research\, Teaching and Patient Care” will be held on March 20\, 2021 as part of the 2021 Demystifying Medicine Series. \nThe 2021 Demystifying Medicine Series\, which is jointly sponsored by FAES and NIH\, will begin January 12 and includes the presentation of patients\, pathology\, diagnosis and therapy in the context of major disease problems and current research. Primarily directed toward Ph.D. students\, clinicians and program managers\, the course is designed to help bridge the gap between advances in biology and their application to major human diseases. Each session includes clinical and basic science components presented by NIH staff and invitees. All students\, fellows and staff are welcome\, as well. \nAbout the Speaker \nEzekiel J. Emanuel is the Vice Provost for Global Initiatives\, the Diane v.S. Levy and Robert M. Levy University Professor\, and Co-Director of the Healthcare Transformation Institute at the University of Pennsylvania. From January 2009 to January 2011\, Dr. Emanuel served as a Special Advisor on Health Policy to the Director of the Office of Management and Budget and National Economic Council. Prior to that he was the founding chair of the Department of Bioethics at the National Institutes of Health from 1997 to August of 2011. Dr. Emanuel received his M.D. from Harvard Medical School and his Ph.D. in political philosophy from Harvard University. After completing his internship and residency in internal medicine at Boston’s Beth Israel Hospital and his oncology fellowship at the Dana-Farber Cancer Institute\, he joined the faculty at the Dana-Farber Cancer Institute. He has since been a visiting professor at the University of Pittsburgh School of Medicine\, UCLA\, the Brin Professor at Johns Hopkins Medical School\, and the Kovitz Professor at Stanford Medical School and visiting professor at New York University Law School. Dr. Emanuel served on President Clinton’s Health Care Task Force\, the National Bioethics Advisory Commission (NBAC)\, and on the bioethics panel of the Pan-American Healthcare Organization. He has published over 300 articles mainly on health care reform\, research ethics\, and end of life care. He has also authored or edited 15 books. \nPlease visit the NIH Demystifying Medicine website for more information.
URL:https://globalbiodefense.com/event/how-covid-19-pandemic-changes-medical-research-teaching-and-patient-care/
CATEGORIES:Government Hosted,Webinar-Webcast,Workshop
LOCATION:https://videocast.nih.gov/watch=41575
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210326T120000
DTEND;TZID=America/New_York:20210326T130000
DTSTAMP:20210317T180939Z
CREATED:20210317T180939Z
LAST-MODIFIED:20210317T180939Z
UID:48964-1616760000-1616763600@globalbiodefense.com
SUMMARY:Drones and the Future of CBRN Threats
DESCRIPTION:The Schar School of Policy and Government Center for Security Policy Studies will host an expert panel discussion on March 26 on “Drones and the Future of Chemical\, Biological\, Radiological and Nuclear (CBRN) Threats“. \nThe event explores the risks posed by the convergence of chemical\, biological\, radiological\, and nuclear CBRN weapons and drones. \nDrones allow terrorists to collect intelligence prior to an attack\, bypass ground-based physical barriers\, and carry out highly effective chemical and biological weapons attacks. For state actors\, the growth and proliferation of drone swarms offer new\, sophisticated ways to carry out CBRN attacks\, defeat traditional CBRN weapons\, and respond to a successful attack. At the same time\, the United States Department of Defense is working hard to combat these threats and recently issued a new strategy around countering small drones. \nThe underlying question spanning the panel is: how well prepared is the United States and the global community to tackle the challenges drones pose for CBRN warfare? And what more can be done? \nABOUT THE SPEAKERS\nNicole Thomas \nDivision Chief for Strategy and Policy @Joint Counter-UAS Office\, Department of Defense \nNicole Thomas is a civilian with the U.S. Army and the Division Chief for Strategy and Policy in the Joint Counter-Small Unmanned Aircraft Systems Office. She is a graduate of the United States Army War College. \nZak Kallenborn \nPolicy Fellow @Schar School of Policy and Government \nZachary Kallenborn is an analyst in horrible ways people kill each other: weapons of mass destruction\, WMD terrorism\, and drone swarms. Officially\, he’s a Policy Fellow at the Center for Security Policy Studies at the Schar School of Policy and Government; a Research Affiliate with the Unconventional Weapons and Technology Division at the National Consortium for the Study of Terrorism and Responses to Terrorism (START)\, headquartered at the University of Maryland; an officially proclaimed U.S. Army “Mad Scientist”\, and a national security consultant. \nGregory Koblentz \nAssociate Professor and Director\, Biodefense Program @Schar School of Policy and Government \nGregory Koblentz is an associate professor and director of the biodefense program at George Mason University’s Schar School of Policy and Government. Dr. Koblentz has authored\, co-authored\, or edited multiple books on nuclear and biological threats and published widely on biodefense\, biosecurity\, dual-use research\, and the proliferation of nuclear\, biological\, and chemical weapons. Dr. Koblentz earned his PhD in political science at the Massachusetts Institute of Technology and his MPP from the Kennedy School at Harvard University. \nSign up today: http://bit.ly/CBRNEdronethreat
URL:https://globalbiodefense.com/event/drones-and-the-future-of-cbrn-threats/
CATEGORIES:Webinar-Webcast
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2021/03/drones-future-chemical-biological-radiological-nuclear-terrorism-cbrn-gmu-schar-school.png
LOCATION:https://gmu.zoom.us/webinar/register/WN_rbyQGYhzRM-whjZb9qD0pA/?source=stemarmedia
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210324T180000
DTEND;TZID=America/New_York:20210324T190000
DTSTAMP:20210308T081252Z
CREATED:20210308T081144Z
LAST-MODIFIED:20210308T081252Z
UID:48779-1616608800-1616612400@globalbiodefense.com
SUMMARY:Policy Exchange: Pandemic Preparedness and Response – Are We Learning the Right Lessons?
DESCRIPTION:Policy Exchange: Pandemic Preparedness and Response – Are We Learning the Right Lessons? will be held March 24\, 2021 6:00 p.m. – 7:00 p.m. ET. \nThe COVID-19 pandemic revealed how vulnerable the world was to the spread of a novel contagious pathogen\, and the United States found itself unprepared and unable to respond effectively to the pandemic. Join Schar School professors\, who are distinguished experts in global health security and pandemic response\, for an interactive discussion about whether we are learning the right lessons and how to prepare for the next pandemic. \nABOUT THE SPEAKERS \nSchar School of Policy and Government Adjunct Professor Robert V. House \nProfessor Robert V. House\, PhD\, MSPH is senior vice president of government contracts at Ology Bioservices Inc.\, a company that develops and manufactures biopharmaceutical products\, including medical countermeasures (MCM)\, for the US government and commercial companies. Prior to Ology Bio\, Dr. House was President and Chief Scientific Officer at DynPort Vaccine Company\, which was also engaged in developing MCM for the US government. \nSchar School of Policy and Government Adjunct Professor Laura Quattrochi \nProfessor Lauren Quattrochi\, PhD\, MA\, MA is currently a principal biotechnologist at MITRE Corporation leading national-level scientific and biosecurity initiatives within the US government. Classically trained as an electrophysiologist and neuro-pharmacologist\, she has worked within the biopharma industry\, non-profits\, and for the past 4 years\, in support of the government. Dr. Quattrochi serves as a technical advisor on both Hantavirus and COVID-19 vaccine development and manufacturing programs. \nSchar School of Policy and Government Assistant Professor Saskia Popescu \nProfessor Saskia Popescu\, PhD\, MPH\, MA\, CIC\, a Schar School alumna\, is an infectious disease epidemiologist and infection preventionist with a focus on hospital bio-preparedness and the role of infection prevention in health security efforts. She currently serves as a member of the Federation of American Scientists (FAS) Coronavirus Taskforce and is a member of the Committee on Data Needs to Monitor Evolution of SARS-CoV-2 with the National Academies of Sciences\, Engineering\, and Medicine (NASEM). \nSchar School of Policy and Government Adjunct Professor Katalin Kiss \nProfessor Katalin Kiss is senior manager at the American Type Culture Collection (ATCC)\, a global biological materials resource and standards organization. She teaches the BIOD 604 Emerging Infectious Diseases 1 – Bacteria and Toxins course in the Master’s in Biodefense program. \nRegister today at the Schar School website.
URL:https://globalbiodefense.com/event/policy-exchange-pandemic-preparedness-and-response-are-we-learning-the-right-lessons/
CATEGORIES:Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2021/03/gmu-pandemic-preparedness-response-policy-exchange-1.jpg
LOCATION:https://masongradevent.secure.force.com/events/targetX_eventsb__events#/esr?eid=a1B1I000006yReyUAE
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210324T110000
DTEND;TZID=America/New_York:20210324T150000
DTSTAMP:20201127T193612Z
CREATED:20201127T193433Z
LAST-MODIFIED:20201127T193612Z
UID:48061-1616583600-1616598000@globalbiodefense.com
SUMMARY:Envisioning a Transformed Clinical Trials Enterprise for 2030 - Session 3
DESCRIPTION:The National Academies’ Forum on Drug Discovery\, Development\, and Translation will host a virtual public workshop on Mar 24\, 2021 as part of a web series forum of events to discuss critical policy for advancement of biopharmaceutical innovation nationally and globally. \nThis virtual public workshop will provide a venue for stakeholders to consider a transformed clinical trial enterprise for 2030. Workshop participants will consider lessons learned from progress and setbacks over the past 10 years\, since the previous workshop\, Envisioning a Transformed Clinical Trials Enterprise in the United States\, and\, looking forward\, discuss goals and key priorities for advancing a clinical trials enterprise that is more efficient\, effective\, person-centered\, inclusive\, and integrated into the health delivery system of 2030. \nThe event will consider approaches to build resilience\, sustainability\, and transparency. The discussion will include the convergence and integration of clinical research and clinical practice; data sharing and management; and efficient\, engaging scientific communication. \nBackground\nClinical trials research has changed dramatically over the last decade. The biological\, physical\, and digital spheres are merging; clinical research and health care are at a critical juncture; new approaches enable the collection of data in real-world settings; and new modalities\, such as digital health technologies and artificial intelligence applications\, are changing possibilities for the conduct of clinical research. \nA planning committee of the National Academies of Sciences\, Engineering\, and Medicine will plan and conduct a virtual public workshop designed to consider a transformed clinical trial enterprise for 2030. Key priority challenges and opportunities framing the 2030 agenda are: \n\nDiversity and inclusion of clinical trial participants\nConvergence of clinical research and clinical practice\nClinical trial data sharing\nIncorporation of new technologies into drug research and development\nWorkforce and career development\nPublic engagement and partnership\nRegulatory Environment\nCultural and Financial Incentives\nPractical short- and long-term goals for improving the efficiency\, effectiveness\, person-centeredness\, inclusivity\, and integration with healthcare of the clinical trials enterprise.\n\nFor additional information on the workshop series\, please visit the project page.
URL:https://globalbiodefense.com/event/envisioning-a-transformed-clinical-trials-enterprise-for-2030-session-3/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:https://bit.ly/nasem-clinicaltrialenterprise
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210323T170000
DTEND;TZID=America/Los_Angeles:20210323T180000
DTSTAMP:20210223T213409Z
CREATED:20210223T213409Z
LAST-MODIFIED:20210223T213409Z
UID:48593-1616518800-1616522400@globalbiodefense.com
SUMMARY:COVID Seminar Series: Testing\, Testing\, 1-2-3
DESCRIPTION:The Pacific Northwest National Laboratory will host a virtual Demystifying COVID Seminar Series event entitled\, “Testing\, Testing\, 1\, 2\, 3 (And What’s Up with The New Vaccine\, Anyways?)” on March 23\, 2021. \nThe Pacific Northwest National Laboratory’s Community Science and Technology Seminar Series was launched to help the general public better understand and explore how science transforms our world. \nABOUT THE SPEAKER \nDr. Kristin Omberg is the group leader of the Chemical and Biological Signatures group at PNNL. Her technical work entails developing solutions with practical utility\, in addition to policy implications. She recently worked with the Departments of Energy and Health and Human Services to evaluate methods for COVID-19 specimen analysis. She received her Ph.D. in Chemistry from the University of North Carolina at Chapel Hill. \nRegister for the event here.
URL:https://globalbiodefense.com/event/covid-seminar-series-testing-testing-1-2-3/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://pnnl.zoomgov.com/webinar/register/WN_MfTKd8agQ82DiAZOkWKd9g
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210323T110000
DTEND;TZID=America/New_York:20210323T123000
DTSTAMP:20210308T083543Z
CREATED:20210308T083113Z
LAST-MODIFIED:20210308T083543Z
UID:48787-1616497200-1616502600@globalbiodefense.com
SUMMARY:Chemical Weapons Arms Control at a Crossroads: Russia\, Syria\, and the Future of the Chemical Weapons Convention
DESCRIPTION:Chemical Weapons Arms Control at a Crossroads: Russia\, Syria\, and the Future of the Chemical Weapons Convention\nMarch 23\, 2021 11:00 a.m. – 12:30 p.m. ET \nThe repeated use of chemical weapons by Syria and Russia threatens to undermine international efforts to eliminate these weapons. How will state parties to the Chemical Weapons Convention\, which bans the development and use of chemical weapons\, respond to these violations of the treaty at their annual meeting in April? \nA guest panelist will join Schar School Professor Gregory Koblentz to discuss the challenges posed by the current Russian and Syrian chemical weapons programs\, the status of international efforts to strengthen accountability for use of chemical weapons\, and the implications for global chemical weapons arms control. \nABOUT THE SPEAKERS \nDr. Hanna Notte\, Senior Non-Resident Scholar at the James Martin Center for Nonproliferation Studies (CNS)\, Berlin \nHanna Notte is a Senior Non-Resident Scholar with the James Martin Center for Nonproliferation Studies (CNS)\, currently based in Berlin\, and focusing on arms control and security issues involving Russia\, the Middle East\, their intersection\, and implications for US/European strategy and policy. Prior to that\, she was a Senior Political Officer with The Shaikh Group\, a non-profit political consultancy focused on informal diplomacy and Track II mediation in the Middle East. Dr. Notte wrote her DPhil on US-Russian cooperation in the Middle East at the University of Oxford (2017\, St. Antony’s College)\, from where she also received an MPhil in International Relations in 2014. She has held visiting research positions with the Institute of Oriental Studies in Moscow\, the Carnegie Moscow Center\, the IISS Middle East office in Manama and the Konrad-Adenauer-Foundation’s Syria/Iraq office in Beirut. She is a German national who speaks Russian\, Arabic\, and French. \nDr. John Walker\, Former Head of the Arms Control and Disarmament Research Unit (ACDRU) at the Foreign and Commonwealth Office\, United Kingdom \nDr John R Walker was Head of the Foreign and Commonwealth Office’s Arms Control and Disarmament Research Unit (ACDRU) from December 2014 to May 2020 when he retired from the FCO. He joined ACDRU in March 1985. John’s main focus was on the Biological and Toxin Weapons Convention (BTWC)\, the Chemical Weapons Convention (CWC)\, the Comprehensive Nuclear Test Ban Treaty (CTBT)\, and the UN Secretary-General’s Mechanism for investigating allegations of CBW use. In addition\, his work also included UK nuclear weapons and arms control history and nuclear disarmament verification. He is currently a Senior Associate Fellow at the European Leadership Network and a Senior Associate Fellow at the Royal United Services Institute. \nDr. Una Jacob\, Research Associate at the Peace Research Institute Frankfurt (PRIF) \nUna Jakob is a research associate at the Peace Research Institute Frankfurt (PRIF) in Germany who specialises in arms control\, disarmament\, and non-proliferation\, with a special focus on chemical and biological weapons. Her recent publications include Countering the Use of Chemical Weapons in Syria: Options for Supporting International Norms and Institutions\, written in 2019 for the EU Non-Proliferation and Disarmament Consortium\, and WMD Compliance and Enforcement in a Changing Global Context\, co-authored with Carmen Wunderlich and Harald Müller for UNIDIR (2021\, forthcoming). She holds a PhD in Political Science from Frankfurt University. \nRegister today: http://bit.ly/scharchemicalweapons
URL:https://globalbiodefense.com/event/chemical-weapons-arms-control-at-a-crossroads-russia-syria-and-the-future-of-the-chemical-weapons-convention/
CATEGORIES:Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2021/03/210323-chemical-weapons-arms-control-talk.jpg
LOCATION:https://gmu.zoom.us/webinar/register/WN_5HGUCsCXSSi4Pw-l1cI3WA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210323T100000
DTEND;TZID=America/New_York:20210323T153000
DTSTAMP:20210225T164735Z
CREATED:20210225T164435Z
LAST-MODIFIED:20210225T164735Z
UID:48641-1616493600-1616513400@globalbiodefense.com
SUMMARY:Holding the Line on Biodefense: Supporting First Line Response to Large-Scale Biological Events
DESCRIPTION:The Bipartisan Commission on Biodefense will host a virtual meeting on March 23\, 2021 to explore the needs of the first responder community and how the federal government can better support non-federal response to future biological incidents. \nSpeakers will include:\n▪ Philip Francisco\, Chief of Police\, Navajo Police Department\n▪ Dia Gainor\, Executive Director\, National Association of State Emergency Medical Services\n▪ Shumeane L. Benford\, Chief of Emergency Management\, City of Boston\, Massachusetts \nPlease visit the Bipartisan Commission on Biodefense website for more information.
URL:https://globalbiodefense.com/event/holding-the-line-on-biodefense-supporting-first-line-response-to-large-scale-biological-events/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210317T110000
DTEND;TZID=America/New_York:20210317T130000
DTSTAMP:20210226T153941Z
CREATED:20210226T153751Z
LAST-MODIFIED:20210226T153941Z
UID:48665-1615978800-1615986000@globalbiodefense.com
SUMMARY:Moving Past COVID-19: Lessons Learned from Responses around the World - Syndemics Webinar
DESCRIPTION:A planning committee of the National Academies of Sciences\, Engineering\, and Medicine host a public webinar entitled ‘Moving Past COVID-19: Lessons Learned from Responses around the World’ on March 17\, 2021. \nBefore the panel discussion\, Richard Horton\, Editor-in-Chief of The Lancet\, will kick off the webinar by providing a detailed description of how public health officials and the public at large ought to understand a syndemic and its sociobiological conditions and discuss the importance of using the syndemic lens to understand disease outbreaks and responses to them. \nPanel Discussion\nLaura Helmuth\, Moderator\nEditor-in-Chief\, Scientific American \nRichard Horton\, Panelist\nEditor-in-Chief\, The Lancet \nTBD\, Panelist\nAmerican Public Health Official \nChikwe Ihekweazu\, Panelist\nDirector General\, Nigeria Centre for Disease Control \n• Outline what we might learn\, from looking at COVID-19 through the lens of a syndemic\, about the long-term consequences that are likely to surface across society and around the world – settling on specific considerations for future analysis \n• Evaluate the practical implications and applicability of using the syndemic lens\, based on lived experience of public health leadership on the ground during COVID-19 \n• Discuss key actions and topics for deeper investigation when planning for long-term\, resilient\nrecovery from COVID-19 \nPlease visit the Moving Past COVID-19: Lessons Learned from Responses around the World – Syndemics Webinar page for more information. \n 
URL:https://globalbiodefense.com/event/moving-past-covid-19-lessons-learned-from-responses-around-the-world-syndemics-webinar/
CATEGORIES:Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2021/02/moving-past-covid-19-nasem-lessons-learned.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210316T180000
DTEND;TZID=America/New_York:20210316T190000
DTSTAMP:20210313T225226Z
CREATED:20210313T225226Z
LAST-MODIFIED:20210313T225226Z
UID:48926-1615917600-1615921200@globalbiodefense.com
SUMMARY:Global Health Security and Diplomacy in the Age of Coronavirus
DESCRIPTION:The Georgetown University Global Health Initiative will host a virtual discussion on “Global Health Security and Diplomacy in the Age of Coronavirus – A Conversation with Ambassador Bonnie Jenkins” on March 16\, 2021. \nAs the COVID-19 pandemic has shown\, the need to effectively and efficiently prevent\, detect\, and respond to emerging infectious diseases and other chemical and biological threats is paramount. For global health authorities around the world\, challenges lie in promoting a collaborative and coordinated approach when implementing global health security programs. With Ambassador Bonnie Jenkins\, the class will discuss a range of topics including her experience as a leader and a woman of color in the field of global health security\, the U.S. State Department’s role in global health\, the implementation of the Global Health Security Agenda\, and the challenges of biological\, chemical\, and nuclear threats the international community faces in the future. \nFEATURED SPEAKERS \nAmbassador Bonnie Jenkins has been nominated to be undersecretary of state for arms control and international security affairs under President Joe Biden. She also is an adjunct professor at the Georgetown University School of Foreign Service and Georgetown Law; the founder and executive director of the Women of Color Advancing Peace\, Security and Conflict Transformation; and chair of the Committee on Radioactive Sources: Applications and Alternative Technologies of the National Academies of Sciences. Previously\, she served as coordinator for Threat Reduction Programs under President Barack Obama and was part of the U.S. government interagency team that launched the Global Health Security Agenda. \nJohn Monahan is the senior advisor for global health to President John J. DeGioia; senior fellow\, McCourt School of Public Policy; and senior scholar\, O’Neill Institute for National and Global Health Law. \n 
URL:https://globalbiodefense.com/event/global-health-security-and-diplomacy-in-the-age-of-coronavirus/
CATEGORIES:Webinar-Webcast
LOCATION:https://globalhealth.georgetown.edu/events/global-health-security-and-diplomacy-in-the-age-of-coronavirus
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210316T170000
DTEND;TZID=America/Los_Angeles:20210316T180000
DTSTAMP:20210223T213652Z
CREATED:20210223T213652Z
LAST-MODIFIED:20210223T213652Z
UID:48595-1615914000-1615917600@globalbiodefense.com
SUMMARY:Behind the Mask: The Science on Stopping the Spread
DESCRIPTION:The Pacific Northwest National Laboratory will host a virtual Demystifying COVID Seminar Series event entitled\, “Behind the Mask: The Science on Stopping the Spread” on March 16\, 2021. \nThe Pacific Northwest National Laboratory’s Community Science and Technology Seminar Series was launched to help the general public better understand and explore how science transforms our world. \nABOUT THE SPEAKER \nDr. Katrina Waters is the division director for Biological Sciences at PNNL and leads the DOE project for Viral Fate and Transport of COVID-19. Her research interests focus on understanding exposure to chemicals\, the mechanisms that lead to disease\, and network modeling of infectious diseases. She received her Ph.D. in Biochemistry from the University of Wisconsin. \nRegister for the event here.
URL:https://globalbiodefense.com/event/behind-the-mask-the-science-on-stopping-the-spread/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://pnnl.zoomgov.com/webinar/register/WN_W0v876qlTD6Xs8Vmu1_DDQ
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210316T150000
DTEND;TZID=America/New_York:20210316T170000
DTSTAMP:20210225T160929Z
CREATED:20210225T160929Z
LAST-MODIFIED:20210225T160929Z
UID:48629-1615906800-1615914000@globalbiodefense.com
SUMMARY:Consequences of Retroviral DNA Integration to AIDS and Evolution
DESCRIPTION:An NIH virtual presentation entitled “These Viruses are Forever: Consequences of Retroviral DNA Integration to AIDS and Evolution” will be held on March 16\, 2021 as part of the 2021 Demystifying Medicine Series. \nThe 2021 Demystifying Medicine Series\, which is jointly sponsored by FAES and NIH\, will begin January 12 and includes the presentation of patients\, pathology\, diagnosis and therapy in the context of major disease problems and current research. Primarily directed toward Ph.D. students\, clinicians and program managers\, the course is designed to help bridge the gap between advances in biology and their application to major human diseases. Each session includes clinical and basic science components presented by NIH staff and invitees. All students\, fellows and staff are welcome\, as well. \nAbout the Speaker \nJohn Coffin is an American Cancer Society Professor of Molecular Biology\, Tufts Graduate School of Biomedical Sciences \nEducation:\nBA\, Biology\, Wesleyan University\nPhD\, Molecular Biology\, University of Wisconsin\, Madison\nPostdoctoral Training\, Institut für Molekularbiologie\, University of Zürich \nOur research interests revolve around obtaining a better understanding of the interaction of retroviruses with their host cells and organisms. We use simple retroviruses (avian and murine viruses) as well as HIV to elucidate the nature of the retrovirus-receptor interaction; control of viral gene expression; mechanism of retroviral genetic variation; and evolution of the host-virus relationship\, as revealed by the fossil record provided by endogenous proviruses found in the normal DNA of all vertebrates and many other species. \nPlease visit the NIH Demystifying Medicine website for more information.
URL:https://globalbiodefense.com/event/consequences-of-retroviral-dna-integration-to-aids-and-evolution/
CATEGORIES:Government Hosted,Webinar-Webcast,Workshop
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210316
DTEND;VALUE=DATE:20210320
DTSTAMP:20210226T142745Z
CREATED:20210226T142627Z
LAST-MODIFIED:20210226T142745Z
UID:48662-1615852800-1616198399@globalbiodefense.com
SUMMARY:Examining the Long-term Health and Economic Effects of Antimicrobial Resistance in the United States
DESCRIPTION:The National Academies will convene a meeting Examining the Long-term Health and Economic Effects of Antimicrobial Resistance in the United States on March 16-19\, 2021 via virtual format. \nDuring these meetings\, expert speakers will discuss GARP’s work developing treatments for drug-resistant infections and CMS reimbursement for new antibiotics. Speakers will also present on the challenges of using genomic data for surveillance and the role of next-generation sequencing and predictive modeling. \nThe following portions of the meeting are open to the public: \n\nMarch 16\, 2021\, 11:00am – 12:05pm ET\nMarch 19\, 2021\, 11:00am – 11:45pm ET\n\nThe agenda for the open session include a discussion of: \n\nGARDP and Antimicrobial Development\, Jennifer Schneider\, Senior Advisor External Affairs\, Global Antibiotic R&D\, Partnership\nInpatient Reimbursement and the Antimicrobial Market\, Anand Shah\, former Deputy Commissioner for Medical and Scientific Affairs\, FDA\nDirect\, Predictive Application of Sequencing and Informatics\, Gautam Dantas\, Professor\, Washington University School of Medicine\n\nDuring the closed sessions across both days\, the committee members will discuss draft recommendations and conclusions in the following areas: \n\nPush and Pull Incentives\nInternational Action\nHealth and Economic Burden\nSurveillance
URL:https://globalbiodefense.com/event/examining-the-long-term-health-and-economic-effects-of-antimicrobial-resistance-in-the-united-states/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210312T110000
DTEND;TZID=America/New_York:20210312T130000
DTSTAMP:20210301T213238Z
CREATED:20210201T205228Z
LAST-MODIFIED:20210301T213238Z
UID:48716-1615546800-1615554000@globalbiodefense.com
SUMMARY:BARDA Vaccines Against AMR Threats Virtual Workshop
DESCRIPTION:Join the Biomedical Advanced Research and Development Authority (BARDA) at the Vaccines against AMR Threats virtual workshop on March 12\, 2021 from 11:00am – 1:00pm Eastern. \nMulti-drug resistant (MDR) organisms are a threat to national security and public health. As rates of antimicrobial resistance (AMR) in pathogens continue to increase new therapeutics and vaccines are essential to combat the growing crisis. \nJoin the workshop to learn more about BARDA and how they plan to tackle this growing threat. \nHighlights from the agenda include: \n\nBARDA Introduction: Dr. Gary Disbrow\, BARDA Director\nCBRN Overview: Dr. Christopher Houchens\, CBRN Director\nAntibacterials Branch Overview: Dr. Mark Albrecht\, Antibacterials Branch Chief\nVaccines Branch Overview: Dr. Daniel Wolfe\, Vaccines Branch Chief (Acting)\nCARB-X Overview: Dr. Cameron Bess\, CARB-X Program Manager\nAMR Threats of Interest for Funding Opps: Dr. Julie Bergmann\, Dr. Lindsay Parish\, Dr. Rushyannah Killens-Cade\, CBRN Project Officers\nBARDA Solicitation Process: Ms. Jill Johnson\, DCMA Branch Chief\nQ&A Structured Discussion: Dr. Julie Bergmann\, Dr. Lindsay Parish\, Dr. Rushyannah Killens-Cade\, CBRN Project Officers\n\nVisit MedicalCountermeasures.gov for more information on this event. \n  \n 
URL:https://globalbiodefense.com/event/barda-vaccines-against-amr-threats-virtual-workshop/
CATEGORIES:Government Hosted,Industry Day,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210309T170000
DTEND;TZID=America/Los_Angeles:20210309T180000
DTSTAMP:20210223T212955Z
CREATED:20210223T212553Z
LAST-MODIFIED:20210223T212955Z
UID:48585-1615309200-1615312800@globalbiodefense.com
SUMMARY:Demystifying COVID: What Do Bats Have to Do With It?
DESCRIPTION:The Pacific Northwest National Laboratory will host a virtual Demystifying COVID Seminar Series event entitled\, “What Do Bats Have to Do With It?” on March 9\, 2021. \nBats\, pangolins\, and humans—oh my! This talk will explore the role wild animals play in the emergence of new diseases– including how they spread\, what symptoms they produce in humans\, how their origins influence their evolution\, and more. You will leave with a better understanding of coronaviruses prior to the COVID-19 pandemic\, currently\, and what we can prepare for in the future. \nThe Pacific Northwest National Laboratory’s Community Science and Technology Seminar Series was launched to help the general public better understand and explore how science transforms our world. \nABOUT THE SPEAKER \nDr. Amy Sims is a virologist at PNNL who studies how the DNA manipulation strategies of viral attacks widens the path to future therapies. For instance\, epigenetic modifications could help govern disease outcomes and sidestep immunity responses. She earned her PhD at Vanderbilt University Medical Center and spent fifteen years at the University of North Carolina Chapel Hill before recently coming to PNNL. \nRegister for the event here. \n  \n 
URL:https://globalbiodefense.com/event/pnnl-covid-seminar-series-what-do-bats-have-to-do-with-it/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://pnnl.zoomgov.com/webinar/register/WN_6Xs9wD9yTWaCWWK0kOf7jw
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210309T160000
DTEND;TZID=America/New_York:20210309T180000
DTSTAMP:20210225T163128Z
CREATED:20210225T155238Z
LAST-MODIFIED:20210225T163128Z
UID:48625-1615305600-1615312800@globalbiodefense.com
SUMMARY:Ethics in Vaccine Development\, Testing and Use Making a COVID-19 Vaccine
DESCRIPTION:A virtual presentation on “Ethics in Vaccine Development\, Testing and Use Making a COVID-19 Vaccine” will be held on March 9\, 2021 as part of the 2021 Demystifying Medicine Series. \nThe 2021 Demystifying Medicine Series\, which is jointly sponsored by FAES and NIH\, will begin January 12 and includes the presentation of patients\, pathology\, diagnosis and therapy in the context of major disease problems and current research. Primarily directed toward Ph.D. students\, clinicians and program managers\, the course is designed to help bridge the gap between advances in biology and their application to major human diseases. Each session includes clinical and basic science components presented by NIH staff and invitees. All students\, fellows and staff are welcome\, as well. \nAbout the Speakers \nKizzmekia Corbett\, PhD is a research fellow and the scientific lead for the Coronavirus Vaccines & Immunopathogenesis Team at the National Institutes of Health (NIH)\, National Institute of Allergy and Infectious Diseases\, Vaccine Research Center (VRC). She received a B.S. in Biological Sciences\, with a secondary major in Sociology\, in 2008 from the University of Maryland – Baltimore County\, where she was a Meyerhoff Scholar and an NIH undergraduate scholar. She then enrolled at University of North Carolina at Chapel Hill\, where she obtained her Ph.D. in Microbiology and Immunology in 2014. A viral immunologist by training\, Dr. Corbett uses her expertise to propel novel vaccine development for pandemic preparedness. Appointed to the VRC in 2014\, her work focuses on developing novel coronavirus vaccines\, including mRNA-1273\, a leading candidate vaccine against the virus that causes COVID-19. In response to the ongoing global COVID-19 pandemic\, the vaccine concept incorporated in mRNA-1273 was designed by Dr. Corbett’s team from viral sequence data and rapidly deployed to industry partner\, Moderna\, Inc.\, for U.S. Food and Drug Administration (FDA)-approved Phase 1 clinical trial\, which unprecedently began only 66 days from the viral sequence release. Following promising results in animal models and humans\, mRNA-1273 is currently in Phase 3 clinical trial. Alongside mRNA-1273\, Dr. Corbett’s team boasts a portfolio that also includes universal coronavirus vaccine concepts and novel therapeutic antibodies. Additionally\, Dr. Corbett spent several years working on a universal influenza vaccine\, which is slated for Phase 1 clinical trial. In all\, she has 15 years of expertise studying dengue virus\, respiratory syncytial virus\, influenza virus and coronaviruses. Along with her research activities\, Dr. Corbett is an active member of the NIH Fellows Committee and avid advocator of STEM education and vaccine awareness in the community. Combining her research goals with her knack for mentoring\, Dr. Corbett aims to become an independent principal investigator. \nChristine Grady\, PhD is a nurse-bioethicist and a senior investigator who currently serves as the Chief of the Department of Bioethics. Dr. Grady has authored more than 175 papers in the biomedical and bioethics literature and authored or edited several books\, including The Oxford Textbook of Clinical Research Ethics. She served from 2010-2017 as a Commissioner on the President’s Commission for the Study of Bioethical Issues. Her work is known internationally\, and she has lectured widely on ethical issues in clinical research and clinical care\, HIV disease\, and nursing. She is an elected fellow of the Hastings Center and of the American Academy of Nursing\, a senior research fellow at the Kennedy Institute of Ethics and an elected member of the National Academy of Medicine. She holds a BS in nursing and biology from Georgetown University\, a MSN. in community health nursing from Boston College\, and a PhD in philosophy from Georgetown University. She has participated in numerous intergovernmental task forces and is the recipient of several awards\, including the NIH CEO Award in 2017\, and the NIH Director’s Award in 2015 and 2017. \nPlease visit the NIH Demystifying Medicine website for more information.
URL:https://globalbiodefense.com/event/ethics-in-vaccine-development-testing-and-use-making-a-covid-19-vaccine/
CATEGORIES:Government Hosted,Webinar-Webcast,Workshop
LOCATION:https://videocast.nih.gov/watch=41289
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210309T110000
DTEND;TZID=America/New_York:20210310T160000
DTSTAMP:20210226T160748Z
CREATED:20210126T154128Z
LAST-MODIFIED:20210226T160748Z
UID:48669-1615287600-1615392000@globalbiodefense.com
SUMMARY:Rapid Response by Laboratory Animal Research Institutions During the COVID-19 Pandemic
DESCRIPTION:The National Academies will host a committee meeting on Rapid Response by Laboratory Animal Research Institutions During the COVID-19 Pandemic: Lessons Learned from March 9-10\, 2021. \nRapid (and Precise) COVID-19 Vaccine Development\nBarney Graham\, M.D.\, Ph.D.\, Deputy Director\, Vaccine Research Center\, NIAID\, NIH \nThe COVID-19 Pandemic: The Triumphs and Challenges of Vaccine Development and Use of Animal Models in the Midst of a Pandemic\nIan Moore\, D.V.M.\, Ph.D.\, DACVP\, Investigative Veterinary Pathologist and Section Chief\, Infectious Disease\nPathogenesis Section\, NIAID\, NIH \nBringing Together Stakeholders: Users and Resources\nFranziska Grieder\, D.V.M.\, Ph.D.\, Director\, Office of Research Infrastructure Program\, Division of Program Coordination\, Planning\, and Strategic Initiatives\, NIH \nLessons Learned: NHP Supply\nKurt Derfler\, M.B.A.\, Executive Director of Operations\, Charles River Laboratories \nNonhuman Primate Importation During the SARS-CoV-2 Pandemic\nGale Galland\, D.V.M.\, M.S.\, DACVPM\, Veterinary Medical Officer\, Zoonoses Team\, Quarantine Border Health Services Branch\, Division of Global Migration and Quarantine\, CDC \nOccupational Health in a Pandemic\nMaureen Thompson\, BSN\, RN\, COHN\, RBP(ABSA)\, Safety Officer\, Yerkes National Primate Research Center\nAssociate Director\, Environmental Health and Safety Office\, Emory University \nRisk Assessment and Biosafety Support for SARS-CoV-2 and COVID-19 Research: Challenges in Established ABSL-2 and ABSL-3 Research Programs\nMolly Stitt-Fisher\, PhD\, CPH\, CBSP\, SM(NRCM)\, Rebecca Lingenfelter\, MSPH\, University Biosafety\, Officer/Associate Biosafety Officer and Alternate Responsible\, Official for Select Agents\, Department of Environmental Health and Safety\, University of Pittsburgh \nPublic Messaging and Communications About Animal-Based Research During the COVID-19 Pandemic\nJames O’Reilly\, B.A.\, President\, Massachusetts Society for Medical Research \nVirus Sequence Data During an Outbreak\nEneida Hatcher\, Ph.D.\, Contractor\, National Center for Biotechnology Information\, National Library of Medicine\,\nNIH \nThe Nonhuman Primate Model of SARS-CoV-2 to Test Therapeutic Strategies: Overcoming Challenges and Obstacles Towards Proof of Concept\nKoen Van Rompay\, D.V.M.\, Ph.D.\, Full Research Virologist\, California National Primate Research Center\nUC Davis \nFast Tracking Animal Model Development\, Collaborations\, and Research to Deliver Preclinical Data for Vaccine Antigen Selection\nIsis Kanevsky\, Ph.D.\, Director\, Vaccine Research Unit\, Pfizer \nManagement of a Nonhuman Primate Colony During SARS-CoV-2\nJoyce Cohen\, V.M.D.\, DACLAM\, Associate Director\, Division of Animal Resources\, Yerkes National Primate Research Center\, Emory University \nMaintaining Animal Research Continuity in the Time of COVID-19\nMichael J. Huerkamp\, D.V.M.\, DACLAM\nExecutive Director\, Division of Animal Resources\nEmory University \nResiliency in Animal Research Operations – COVID-19 Lessons Learned: Direct Staffing Impacts\nCDR Temeri Wilder-Kofie\, D.V.M.\, MPH\, DACLAM\, Facility Veterinarian\, Comparative Medicine Branch\, NIAID\, NIH \nResiliency in Animal Research Operations: Laboratory Animal Program Operations and Management Impacts\nJill Ascher\, M.A.\, D.V.M.\, MPH\, DACLAM\, Director\, Division of Veterinary Resources\, Office of Research Services\nNIH \nImpact of the COVID-19 Pandemic on Animal Research\nLori Palley\, D.V.M.\, DACLAM\, Assistant Director of Veterinary Services\, Center for Comparative Medicine\nMassachusetts General Hospital \nFinancial Impact of the COVID-19 Pandemic on Academic Animal Care Programs\nLucy Kennedy\, D.V.M.\, DACLAM\, Assistant Director for Clinical Services and Assistant Attending Veterinarian\, Unit for Laboratory Animal Medicine\, University of Michigan \nEvolving Prioritizations of In Vivo Research in Pharma During the COVID-19 Pandemic\nSean Maguire\, V.M.D.\, M.S.\, MRCVS\, DACLAM\, Comparative & Translational Sciences Director & Associate Fellow\, GlaxoSmithKline \nIntegrating the Institution’s COVID-19 Response Plan into the Research Animal Program\nStephen Denny\, D.V.M.\, M.S.\, DACLAM\, DACVPM\, Director\, Office of Animal Care and Use Office of Intramural Research\, NIH \nPanel Discussion – Resiliency in Animal Research Operations\nOpen panel discussion with audience participation \nPanelists: \n\nAcademia: Mike Huerkamp\, Lucy Kennedy\nGovernment: Jill Ascher\, Temeri Wilder-Kofie\, Stephen Denny\nIndustry – Pharma: Sean Maguire\nPrimate Research Center: Joyce Cohen\nAnimal Research Advocate: James O’Reilly\n\n\nMeeting Materials\n\n\n\nRapid Response Workshop Agenda\nSpeaker Abstracts\nSpeaker Biographies\n\n\nPlease visit the Rapid Response by Laboratory Animal Research Institutions During the COVID-19 Pandemic: Lessons Learned page for more information.
URL:https://globalbiodefense.com/event/rapid-response-by-laboratory-animal-research-institutions-during-the-covid-19-pandemic/
CATEGORIES:Webinar-Webcast,Workshop
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2021/02/rapid-response-animal-research-lab-covid-countermeasures-nasem.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210309
DTEND;VALUE=DATE:20210312
DTSTAMP:20210225T235017Z
CREATED:20210225T235017Z
LAST-MODIFIED:20210225T235017Z
UID:48660-1615248000-1615507199@globalbiodefense.com
SUMMARY:The Current Global Governance Landscape for Influenza
DESCRIPTION:The Health and Medicine Division of the National Academies will convene a virtual committee meeting on the Current Global Governance Landscape for Influenza on March 9-11\, 2021. \nThis first meeting of the committee will serve for the committee to begin to analyze the major global frameworks\, regulations\, and partnerships for influenza vaccine preparedness and response. \nOpen sessions will feature discussions with speakers\, including the sponsor and global health leaders\, about considerations that led to the launch of this consensus study and gaps in or barriers to implementation of current global mechanisms for influenza vaccine development\, manufacturing\, and access. The meeting will allow committee members to identify areas of concentration within the study’s statement of task and determine what information gathering will be required for to make recommendations for these areas. \nPlease visit NASEM’s Current Global Governance Landscape for Influenza Vaccines webpage for more information.
URL:https://globalbiodefense.com/event/the-current-global-governance-landscape-for-influenza/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:
END:VEVENT
END:VCALENDAR